NPI: 1225128432 · GENEVA, OH 44041 · Critical Access Hospital · NPI assigned 10/16/2006
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 10/16/2006 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,684 | $730K |
| 2019 | 20,206 | $565K |
| 2020 | 15,173 | $539K |
| 2021 | 25,965 | $764K |
| 2022 | 29,662 | $977K |
| 2023 | 102,481 | $3.32M |
| 2024 | 71,323 | $2.96M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 16,321 | 14,993 | $2.05M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,896 | 11,066 | $1.56M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,976 | 7,925 | $1.20M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,124 | 3,114 | $988K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,528 | 2,103 | $600K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,302 | 1,849 | $546K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,045 | 2,235 | $402K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,079 | 839 | $281K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,084 | 632 | $182K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 802 | 646 | $181K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 810 | 674 | $169K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,297 | 728 | $155K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,984 | 1,086 | $146K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 412 | 353 | $109K |
| 80053 | Comprehensive metabolic panel | 18,119 | 15,135 | $86K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 396 | 144 | $82K |
| G0378 | Hospital observation service, per hour | 1,863 | 1,053 | $73K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 755 | 285 | $71K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 507 | 460 | $68K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 467 | 380 | $67K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,216 | 980 | $48K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 64 | 61 | $48K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,209 | 2,669 | $44K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,920 | 10,023 | $43K |
| 71250 | 692 | 597 | $39K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 174 | 153 | $33K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 295 | 269 | $31K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 236 | 221 | $31K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 555 | 489 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,655 | 1,327 | $28K |
| 71046 | Radiologic examination, chest; 2 views | 1,688 | 1,443 | $27K |
| 96367 | 627 | 438 | $26K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,727 | 2,611 | $22K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 117 | 92 | $22K |
| 84484 | 10,760 | 6,262 | $22K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 634 | 253 | $20K |
| 71045 | Radiologic examination, chest; single view | 6,121 | 5,139 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 193 | 170 | $17K |
| 97161 | 273 | 241 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 788 | 644 | $14K |
| 82805 | 722 | 465 | $13K | |
| 83605 | 6,920 | 4,812 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 18,792 | 15,781 | $11K |
| 36415 | Collection of venous blood by venipuncture | 9,922 | 7,012 | $10K |
| 72131 | 129 | 96 | $10K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 113 | 104 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 555 | 489 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 835 | 733 | $9K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 18 | 12 | $8K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 22 | 17 | $8K |
| 85027 | 5,169 | 3,821 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,297 | 2,037 | $7K |
| 73630 | 485 | 421 | $7K | |
| 96376 | 1,205 | 699 | $6K | |
| 93971 | 99 | 92 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,690 | 1,959 | $6K |
| 76642 | 55 | 53 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,022 | 5,893 | $6K |
| 94664 | 599 | 491 | $6K | |
| 76830 | Ultrasound, transvaginal | 129 | 116 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | 6,183 | 4,735 | $5K |
| 73030 | 281 | 218 | $4K | |
| 80320 | 219 | 185 | $4K | |
| 74018 | 163 | 142 | $4K | |
| 73130 | 327 | 278 | $4K | |
| 82140 | 264 | 212 | $4K | |
| 73610 | 312 | 289 | $3K | |
| 83880 | 2,224 | 1,757 | $3K | |
| 81001 | 6,401 | 5,476 | $3K | |
| 73110 | 207 | 184 | $3K | |
| 93017 | 21 | 15 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,394 | 1,984 | $2K |
| 82947 | 2,414 | 1,171 | $2K | |
| 86140 | 621 | 494 | $2K | |
| 85610 | 3,573 | 2,948 | $2K | |
| J3490 | Unclassified drugs | 825 | 448 | $2K |
| 87040 | 2,331 | 1,010 | $2K | |
| A9270 | Non-covered item or service | 9,026 | 1,000 | $2K |
| 83735 | 3,347 | 2,577 | $2K | |
| 99215 | Prolong outpt/office vis | 16 | 14 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 63 | 55 | $2K |
| 81003 | 4,146 | 3,591 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 28 | 12 | $2K |
| 93976 | 12 | 12 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 673 | 341 | $2K |
| 94060 | 12 | 12 | $2K | |
| 87634 | 306 | 248 | $2K | |
| 80061 | Lipid panel | 101 | 78 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,344 | 1,175 | $1K |
| 86850 | 51 | 37 | $1K | |
| 83690 | 3,539 | 2,883 | $1K | |
| 73564 | 108 | 92 | $989.65 | |
| 90715 | 117 | 108 | $954.85 | |
| 82077 | 697 | 540 | $939.53 | |
| 86900 | 68 | 52 | $884.79 | |
| 80076 | 367 | 276 | $869.71 | |
| 80143 | 633 | 499 | $839.07 | |
| 87631 | 28 | 28 | $781.54 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,804 | 3,802 | $758.44 |
| 81025 | 2,097 | 1,728 | $643.69 | |
| 82607 | 32 | 26 | $624.99 | |
| 82550 | 674 | 572 | $618.66 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 6,389 | 4,900 | $605.08 |
| J1170 | Injection, hydromorphone, up to 4 mg | 871 | 462 | $588.81 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 160 | 155 | $576.77 |
| 82728 | 162 | 116 | $572.90 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 99 | 85 | $516.02 |
| 94729 | 13 | 13 | $487.41 | |
| 84702 | 580 | 483 | $479.96 | |
| 80179 | 621 | 495 | $450.33 | |
| 73502 | 28 | 26 | $413.64 | |
| 70486 | 16 | 14 | $399.64 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 37 | 25 | $380.18 |
| 85379 | 1,129 | 910 | $358.45 | |
| 82330 | 660 | 417 | $345.67 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 753 | 608 | $344.95 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 874 | 303 | $324.35 |
| 73080 | 15 | 13 | $324.29 | |
| 83540 | 140 | 101 | $308.13 | |
| 87075 | 912 | 437 | $296.85 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 946 | 622 | $292.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,408 | 3,488 | $266.33 |
| 85018 | 647 | 437 | $241.79 | |
| 85730 | 405 | 343 | $224.08 | |
| 83550 | 136 | 99 | $214.86 | |
| C9113 | Injection, pantoprazole sodium, per vial | 214 | 155 | $210.72 |
| 85652 | 243 | 196 | $207.53 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 126 | 115 | $205.25 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 564 | 320 | $202.56 |
| 84132 | 672 | 444 | $162.13 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,484 | 1,913 | $158.23 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 925 | 447 | $153.72 |
| 87077 | 315 | 190 | $146.76 | |
| 87449 | 198 | 191 | $145.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,012 | 708 | $142.27 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 361 | 162 | $140.81 |
| 82435 | 539 | 370 | $126.22 | |
| 87186 | 379 | 270 | $120.99 | |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | 19 | 15 | $113.43 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,016 | 2,999 | $103.02 |
| 86901 | 66 | 51 | $101.99 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 370 | 195 | $101.39 |
| 82248 | 98 | 82 | $92.60 | |
| 87205 | 30 | 25 | $85.93 | |
| 84295 | 541 | 369 | $82.72 | |
| 84100 | 117 | 100 | $75.85 | |
| 82150 | 143 | 133 | $46.91 | |
| 87081 | 100 | 96 | $45.67 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,225 | 932 | $42.06 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 404 | 265 | $37.70 |
| 94760 | 604 | 416 | $34.11 | |
| 36600 | 103 | 69 | $33.57 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 164 | 123 | $32.47 |
| J2704 | Injection, propofol, 10 mg | 877 | 685 | $28.57 |
| 76377 | 111 | 91 | $27.65 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,009 | 794 | $20.70 |
| 82962 | 35 | 12 | $19.38 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 529 | 382 | $18.38 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 39 | 29 | $15.28 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 268 | 193 | $14.90 |
| J7050 | Infusion, normal saline solution, 250 cc | 631 | 350 | $14.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 785 | 522 | $14.04 |
| J2060 | Injection, lorazepam, 2 mg | 136 | 95 | $11.67 |
| 82948 | 57 | 13 | $10.01 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 75 | 63 | $9.96 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 317 | 271 | $6.51 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 241 | 182 | $6.12 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 271 | 152 | $5.97 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 53 | 44 | $3.38 |
| J1644 | Injection, heparin sodium, per 1000 units | 15 | 12 | $2.12 |
| 84145 | 20 | 14 | $0.75 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 22 | 13 | $0.57 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 28 | 24 | $0.00 |
| 99152 | 49 | 41 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 14 | 12 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 19 | 13 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 46 | 27 | $0.00 |
| J7070 | Infusion, d5w, 1000 cc | 37 | 25 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 14 | 12 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 26 | 14 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 84 | 52 | $0.00 |
| 84703 | 29 | 29 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 58 | 48 | $0.00 |
| 80329 | 28 | 12 | $0.00 |